retatrutide nausea Common Side Effects The good, bad and UGLY

Individuals who prefer FDA-approved products should explore platforms that offer Wegovy, Mounjaro, Zepbound, or other branded options - potentially through insurance coverage or manufacturer savings programs

Demand for those medications has far outpaced supply over the past year, forcing Novo Nordisk and Eli Lilly, the dominant players in the market, to invest heavily to scale up manufacturing

Before you consider Eli Lilly and Company, you'll want to hear this

Tirzepatide is administered as a once-weekly subcutaneous injection, with dosing typically initiated at 2.5 mg for 4 weeks, then increased in 2.5 mg increments to a target dose of 5-15 mg based on glycemic control and tolerability

This level of optimization is not necessary for most people